This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Controlled Clinical Trial

Donald S. Robinson, MD; Alexander Nies, MD; C. Lewis Ravaris, MD, PhD; Kathleen R. Lamborn, PhD

Arch Gen Psychiatry. 1973;29(3):407-413.

Abstract
The monoamine oxidase (MAO) inhibitor, phenelzine sulfate, and placebo were compared in a prospective, controlled, double-blind experiment involving 87 outpatients with features of atypical depression. Patients were treated for six weeks while MAO inhibition and symptom severity were monitored. By utilizing a structured depression interview, type and severity of depression were precisely assessed. Sixty patients completed the treatment period. Treatment groups were balanced for such risk factors as age, sex, severity, and type of depressive symptomatology.

Improvement of phenelzine completers was greater than placebo completers for 15 out of 16 prospectively selected measures. Improvement in subscale scores for irritability, hypochondriasis-agitation, and psychomotor change was especially marked with phenelzine. These study findings suggest that MAO inhibitors may have a special efficacy in treating depressive illnesses with atypical features such as anxiety, fatigue, phobia, or other somatic complaints.

Author Affiliations
Burlington, Vt

From the departments of pharmacology (Dr. Robinson), medicine (Dr. Robinson), and psychiatry (Drs. Nies and Ravaris), and the Biometrics Facility (Dr. Lamborn), University of Vermont College of Medicine, Burlington. Dr. Nies is currently with the Department of Psychiatry, Dartmouth Medical School, Hanover, NH.

Footnotes
Accepted for publication March 15, 1973.

Reprint requests to Clinical Pharmacology Unit, University of Vermont, Given Bldg, Burlington, VT 05401 (Dr. Robinson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Atypical Depression: A Reappraisal
Parker et al.
Am. J. Psychiatry 2002;159:1470-1479.
ABSTRACT | FULL TEXT  

Atypical Depression, Panic Attacks, and Response to Imipramine and Phenelzine: A Replication
Quitkin et al.
Arch Gen Psychiatry 1990;47:935-941.
ABSTRACT  

A Controlled Study of the Antidepressant Efficacy and Side Effects of ( -- )-Deprenyl: A Selective Monoamine Oxidase Inhibitor
Mann et al.
Arch Gen Psychiatry 1989;46:45-50.
ABSTRACT  

An Efficacy Study of Isocarboxazid and Placebo in Depression, and Its Relationship to Depressive Nosology
Davidson et al.
Arch Gen Psychiatry 1988;45:120-127.
ABSTRACT  

Antidepressant Specificity in Atypical Depression
Liebowitz et al.
Arch Gen Psychiatry 1988;45:129-137.
ABSTRACT  

Hypochondriasis and Somatization
Kellner
JAMA 1987;258:2718-2722.
ABSTRACT  

l-Deprenyl in Atypical Depressives
Quitkin et al.
Arch Gen Psychiatry 1984;41:777-781.
ABSTRACT  

Phenelzine v Imipramine in Atypical Depression: A Preliminary Report
Liebowitz et al.
Arch Gen Psychiatry 1984;41:669-677.
ABSTRACT  

Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid
Becker et al.
Science 1983;221:476-478.
ABSTRACT  

Atypical Depression
Davidson et al.
Arch Gen Psychiatry 1982;39:527-534.
ABSTRACT  

Treatment of Traumatic War Neurosis With Phenelzine
Hogben and Cornfield
Arch Gen Psychiatry 1981;38:440-445.
ABSTRACT  

Phenelzine and Amitriptyline in the Treatment of Depression: A Comparison of Present and Past Studies
Ravaris et al.
Arch Gen Psychiatry 1980;37:1075-1080.
ABSTRACT  

Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms
Sheehan et al.
Arch Gen Psychiatry 1980;37:51-59.
ABSTRACT  

Monoamine Oxidase Inhibitors: A Review of Antidepressant Effectiveness
Quitkin et al.
Arch Gen Psychiatry 1979;36:749-760.
ABSTRACT  

Clinical Pharmacology of Phenelzine
Robinson et al.
Arch Gen Psychiatry 1978;35:629-635.
ABSTRACT  

Prediction of Tricyclic Antidepressant Response: A Critical Review
Bielski and Friedel
Arch Gen Psychiatry 1976;33:1479-1489.
ABSTRACT  

A Multiple-Dose, Controlled Study of Phenelzine in Depression-Anxiety States
Ravaris et al.
Arch Gen Psychiatry 1976;33:347-350.
ABSTRACT  

Amitriptyline-Perphenazine Interaction in Ambulatory Schizophrenic Patients: A Controlled Study of Drug Interaction
Chouinard et al.
Arch Gen Psychiatry 1975;32:1295-1307.
ABSTRACT  

Overview of Recent Research in Depression: Integration of Ten Conceptual Models Into a Comprehensive Clinical Frame
Akiskal and McKinney
Arch Gen Psychiatry 1975;32:285-305.
ABSTRACT  

Depression Subtypes and Response to Phenelzine, Diazepam, and a Placebo: Results of a Nine Hospital Collaborative Study
Raskin et al.
Arch Gen Psychiatry 1974;30:66-75.
ABSTRACT